Cancer BiologybioRxivPreprint
IL-1β/IRAK4 Axis Promotes Ovarian Tumor Development at the Mesothelium Injury Sites
John P. Miller, Kyukwang Kim, Negar Khazan…·Rakesh K. Singh
This paper develops a MIM model to study EOC metastasis at mesothelial injury sites and shows IRAK4 inhibitors reduce tumor burden more effectively than IL-1/IL-1R1 targeting agents.
1 citation